← Back to Search

Procedure

TAAA Debranching Stent Graft System for Thoracoabdominal Aortic Aneurysms

N/A
Waitlist Available
Led By James H Black, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This study is evaluating whether a new device can be used to repair thoracoabdominal aortic aneurysms.

Eligible Conditions
  • Thoracoabdominal Aortic Aneurysms

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dapsone
Secondary outcome measures
Treatment Success at 1 Year

Trial Design

2Treatment groups
Experimental Treatment
Group I: Primary Study ArmExperimental Treatment3 Interventions
The TAAA Debranching Stent Graft System is comprised of two investigational devices including the Visceral Manifold and Thoracic Bifurcation and the unitary manifold. The thoracic bifurcation and the visceral manifold as well as the unitary manifold work to facilitate endovascular stenting of the visceral vessels (renals, celiac, SMA) while maintaining flow to the visceral and infrarenal segments.
Group II: Expanded Selection ArmExperimental Treatment3 Interventions
The Expanded Selection Arm will be treated the same as those in the Primary Study Arm. Your doctor will determine what arm you are in. TAAA Debranching Stent Graft System is comprised of two investigational devices including the Visceral Manifold and Thoracic Bifurcation and the unitary manifold. The thoracic bifurcation and the visceral manifold as well as the unitary manifold work to facilitate endovascular stenting of the visceral vessels (renals, celiac, SMA) while maintaining flow to the visceral and infrarenal segments.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,262 Previous Clinical Trials
14,823,162 Total Patients Enrolled
James H Black, MDPrincipal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Journal of Vascular SurgeryJournal
A Novel Endovascular Debranching Technique Using Physician-assembled Endografts for Repair of Thoracoabdominal Aneurysms
Anderson, Joe, Madeline Nykamp, Laura Danielson, Tyler Remund, and Patrick W. Kelly. 2014. “A Novel Endovascular Debranching Technique Using Physician-assembled Endografts for Repair of Thoracoabdominal Aneurysms”. Journal of Vascular Surgery. Elsevier BV. doi:10.1016/j.jvs.2014.05.090.
clinicaltrials.govStudy
Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device
2020. "Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03637374.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top